Browsing Category

24267 posts
Milliken & Company Recognized with 2025 EcoVadis Gold Rating, Placing in Top 5% Worldwide

Milliken & Company Recognized with 2025 EcoVadis Gold Rating, Placing in Top 5% Worldwide

SPARTANBURG, S.C., Nov. 5, 2025 /PRNewswire/ — Milliken & Company, a global…
AEWIN Presents Innovative Two-Phase Direct Liquid Cooling (2P DLC) Solution at SC25

AEWIN Presents Innovative Two-Phase Direct Liquid Cooling (2P DLC) Solution at SC25

TAIPEI, Nov. 5, 2025 /PRNewswire/ — AEWIN Technologies Co., Ltd (doing business…
H3C Digital Tour 2025 Successfully Launched in Hong Kong: "Synergy+" Starts a Bright Future for Digital Hong Kong and Macau

H3C Digital Tour 2025 Successfully Launched in Hong Kong: "Synergy+" Starts a Bright Future for Digital Hong Kong and Macau

HONG KONG, Nov. 5, 2025 /PRNewswire/ — On November 4, H3C Digital…
Bangkok’s Vijit Chao Phraya 2025: A Cultural Light Show

Bangkok’s Vijit Chao Phraya 2025: A Cultural Light Show

The “Vijit Chao Phraya 2025” light and sound event in Bangkok runs from 9 November to 23 December, paying tribute to Queen Sirikit. It features drone displays, light-themed installations, and cultural performances along the Chao Phraya River. Highlights include storytelling at 14 landmarks, culminating in a candle-lighting ceremony on New Year’s Eve.
Thoughtworks Technology Radar Highlights The Rapid Evolution of AI Assistance in 2025

Thoughtworks Technology Radar Highlights The Rapid Evolution of AI Assistance in 2025

CHICAGO, Nov. 5, 2025 /PRNewswire/ — Thoughtworks, a global technology consultancy that integrates…

TeamViewer reports rapid customer adoption of its Al offering

TeamViewer Al summarized more than 270,000 remote support sessions, enabling proactive IT…

WF International Announces Pricing of $3.44 Million Follow-on Public Offering

CHENGDU, China, Nov. 5, 2025 /PRNewswire/ — WF International Limited (the "Company"…

BioDlink Congratulates Lepu Biopharma on Securing Approval for the World's First Approved EGFR-Targeted ADC

BioDlink helps Lepu Biopharma win China’s marketing approval for EGFR-targeted ADC treating…